KEVIN OUTTERSON, ESQ.

Executive Director

Prof. Kevin Outterson is the founding Executive Director of CARB-X, the world’s leading public-private partnership that accelerates the early-stage development of innovative products to prevent, diagnose, and treat bacterial infections globally. CARB-X has supported more than 100 R&D projects around the world. 18 of these projects have already reached or surpassed first-in-human clinical trials, including two products already on the market. In 2020, CARB-X was awarded the Innovating for Impact Partnership Award by the Global Health Technologies Coalition (GHTC). CARB-X funders include the governments of the United States (BARDA & NIAID), Germany (BMBF), United Kingdom (GAMRIF), Canada (PHAC), and Japan (MHLW), plus Wellcome, the Novo Nordisk Foundation, and the Bill & Melinda Gates Foundation. Prof. Outterson is also the Austin B. Fletcher Professor of Law at Boston University, where he co-directs the Health Law Program. Prof. Outterson has published ~100 articles and book chapters on health care law, with a focus on incentive problems related to pharmaceutical products, including push and pull incentives for antimicrobials.